Evidence map›Paper›PMID 30772948›Full record

ArticleJournal of cellular and molecular medicine2019

Extracellular vesicles from human umbilical cord mesenchymal stem cells improve nerve regeneration after sciatic nerve transection in rats.

Yongbin Ma, Liyang Dong, Dan Zhou, Li Li, Wenzhe Zhang, Yu Zhen, Ting Wang, Jianhua Su, Deyu Chen, Chaoming Mao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yongbin MaDepartment of Central Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Liyang DongDepartment of Nuclear Medicine and Institute of Oncology, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Dan ZhouDepartment of Neurology Laboratory, Jintan Hospital, Jiangsu University, Jintan, China.
Li LiDepartment of Central Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Wenzhe ZhangDepartment of Central Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Yu ZhenDepartment of Central Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Ting WangDepartment of Central Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Jianhua SuDepartment of Neurology Laboratory, Jintan Hospital, Jiangsu University, Jintan, China.
Deyu ChenDepartment of Nuclear Medicine and Institute of Oncology, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Chaoming MaoDepartment of Nuclear Medicine and Institute of Oncology, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Xuefeng WangDepartment of Central Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.ORCID 0000-0002-5980-6530
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral nerve injury results in limited nerve regeneration and severe functional impairment. Mesenchymal stem cells (MSCs) are a remarkable tool for peripheral nerve regeneration. The involvement of human umbilical cord MSC-derived extracellular vesicles (hUCMSC-EVs) in peripheral nerve regeneration, however, remains unknown. In this study, we evaluated functional recovery and nerve regeneration in rats that received hUCMSC-EV treatment after nerve transection. We observed that hUCMSC-EV treatment promoted the recovery of motor function and the regeneration of axons; increased the sciatic functional index; resulted in the generation of numerous axons and of several Schwann cells that surrounded individual axons; and attenuated the atrophy of the gastrocnemius muscle. hUCMSC-EVs aggregated to rat nerve defects, down-regulated interleukin (IL)-6 and IL-1β, up-regulated IL-10 and modulated inflammation in the injured nerve. These effects likely contributed to the promotion of nerve regeneration. Our findings indicate that hUCMSC-EVs can improve functional recovery and nerve regeneration by providing a favourable microenvironment for nerve regeneration. Thus, hUCMSC-EVs have considerable potential for application in the treatment of peripheral nerve injury.

Indexed as

Nerve RegenerationAnimalsCells, CulturedExtracellular VesiclesHumansMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMuscle, SkeletalMuscular AtrophyPeripheral Nerve InjuriesRatsRats, Sprague-DawleyRecovery of FunctionSciatic NerveUmbilical Cordextracellular vesicleshuman umbilical cord mesenchymal stem cellimprovenerve regenerationsciatic nerve transection

Identifiers

PMID30772948
PMCPMC6433678
OpenAlexW2915270257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.